Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| pericyte | 9 studies | 25% ± 7% | |
| smooth muscle cell | 8 studies | 28% ± 9% | |
| epithelial cell | 8 studies | 31% ± 14% | |
| secretory cell | 5 studies | 24% ± 5% | |
| ciliated cell | 5 studies | 24% ± 12% | |
| club cell | 4 studies | 22% ± 5% | |
| kidney distal convoluted tubule epithelial cell | 4 studies | 22% ± 9% | |
| type II pneumocyte | 4 studies | 23% ± 5% | |
| hepatocyte | 4 studies | 30% ± 8% | |
| goblet cell | 4 studies | 30% ± 10% | |
| respiratory goblet cell | 3 studies | 30% ± 15% | |
| basal cell | 3 studies | 24% ± 8% | |
| endothelial cell | 3 studies | 20% ± 2% | |
| brush cell | 3 studies | 25% ± 7% |
Insufficient scRNA-seq data for expression of GPRC5C at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| liver | 100% | 7095.46 | 226 / 226 | 100% | 56.14 | 405 / 406 |
| kidney | 100% | 7963.74 | 89 / 89 | 99% | 68.25 | 895 / 901 |
| thymus | 100% | 5664.25 | 653 / 653 | 97% | 72.48 | 589 / 605 |
| pancreas | 100% | 3045.23 | 328 / 328 | 96% | 32.91 | 171 / 178 |
| prostate | 99% | 3241.40 | 242 / 245 | 95% | 33.20 | 476 / 502 |
| ovary | 100% | 2495.08 | 180 / 180 | 91% | 36.81 | 390 / 430 |
| stomach | 95% | 10736.17 | 342 / 359 | 89% | 23.34 | 254 / 286 |
| lung | 91% | 1659.60 | 526 / 578 | 83% | 28.27 | 953 / 1155 |
| intestine | 78% | 1704.51 | 753 / 966 | 93% | 26.46 | 492 / 527 |
| uterus | 95% | 1455.09 | 161 / 170 | 75% | 25.91 | 343 / 459 |
| breast | 90% | 1429.64 | 415 / 459 | 77% | 21.35 | 861 / 1118 |
| bladder | 81% | 2010.90 | 17 / 21 | 84% | 36.17 | 424 / 504 |
| esophagus | 69% | 672.85 | 1000 / 1445 | 70% | 21.48 | 129 / 183 |
| adrenal gland | 91% | 1214.76 | 235 / 258 | 23% | 4.86 | 54 / 230 |
| brain | 77% | 1801.52 | 2046 / 2642 | 33% | 4.98 | 236 / 705 |
| muscle | 100% | 4158.50 | 800 / 803 | 0% | 0 | 0 / 0 |
| blood vessel | 99% | 4686.12 | 1325 / 1335 | 0% | 0 | 0 / 0 |
| spleen | 99% | 1587.90 | 238 / 241 | 0% | 0 | 0 / 0 |
| heart | 93% | 1192.67 | 801 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 88% | 12.92 | 70 / 80 |
| adipose | 84% | 1018.19 | 1008 / 1204 | 0% | 0 | 0 / 0 |
| skin | 72% | 1872.83 | 1303 / 1809 | 12% | 2.18 | 55 / 472 |
| tonsil | 0% | 0 | 0 / 0 | 60% | 14.11 | 27 / 45 |
| peripheral blood | 10% | 121.13 | 91 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
| GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
| GO_0070062 | Cellular component | extracellular exosome |
| GO_0043235 | Cellular component | receptor complex |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0031982 | Cellular component | vesicle |
| GO_0030659 | Cellular component | cytoplasmic vesicle membrane |
| GO_0030295 | Molecular function | protein kinase activator activity |
| GO_0004930 | Molecular function | G protein-coupled receptor activity |
| Gene name | GPRC5C |
| Protein name | G protein-coupled receptor class C group 5 member C (G protein-coupled receptor, family C, group 5, member C, isoform CRA_c) (GPRC5C protein) G protein-coupled receptor class C group 5 member C G-protein coupled receptor family C group 5 member C (Retinoic acid-induced gene 3 protein) (RAIG-3) |
| Synonyms | PSEC0087 hCG_1775257 RAIG3 |
| Description | FUNCTION: This retinoic acid-inducible G-protein coupled receptor provide evidence for a possible interaction between retinoid and G-protein signaling pathways. . |
| Accessions | A8MXZ4 ENST00000709195.1 [Q9NQ84-1] ENST00000342648.9 ENST00000709196.1 [Q9NQ84-2] ENST00000582473.2 ENST00000392629.3 [Q9NQ84-1] ENST00000582444.1 J9JIE0 Q9NQ84 J3QQN3 ENST00000581590.1 ENST00000652232.1 Q9BSP0 ENST00000481232.2 ENST00000652294.1 [Q9NQ84-2] J3KSD6 ENST00000392628.7 ENST00000709192.1 [Q9NQ84-1] J3KTP8 ENST00000392627.7 [Q9NQ84-1] A0A0C4DFY5 |